Schmidt, T. M., Barwick, B. G., Joseph, N., Heffner, L. T., Hofmeister, C. C., Bernal, L., . . . Kaufman, J. L. (2019). Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone. Blood Cancer J.
Styl ChicagoSchmidt, Timothy M., et al. "Gain of Chromosome 1q Is Associated With Early Progression in Multiple Myeloma Patients Treated With Lenalidomide, Bortezomib, and Dexamethasone." Blood Cancer J 2019.
Citace podle MLASchmidt, Timothy M., et al. "Gain of Chromosome 1q Is Associated With Early Progression in Multiple Myeloma Patients Treated With Lenalidomide, Bortezomib, and Dexamethasone." Blood Cancer J 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..